Get the tools used by (smart)2 investors.

FCF Levered Cumulative Growth (3y) for Novartis AG

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

0QLR: Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

98.59 CHF
Price
CHF
Fair Value
Upside
83.61 - 115.98
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG's FCF Levered Cumulative Growth (3y):

0QLRHLTH.CHSDZ010683053RO000943981-50.0%0.0%50.0%100.0%

Performance Summary
  • Novartis's fcf levered cumulative growth (3y) is 16.1%

How does Novartis's FCF Levered Cumulative Growth (3y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Novartis AG because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: FCF Levered Cumulative Growth (3y)

Hide this widget
fcf_levered_cumul_growth_3y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to FCF Levered Cumulative Growth (3y) in the growth category include:

View Full List

Search for metric or datapoint

FCF Levered Cumulative Growth (3y)

Cumulative levered free cash flow growth over the last three years

Definition of FCF Levered Cumulative Growth (3y)

Hide this widget
Cumulative levered free cash flow growth over the last three years

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-1,179.6%-679.6%-179.6%699.0%0100200300

The chart above depicts the distribution of fcf levered cumulative growth (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,970 companies were considered in this analysis, and 1,895 had meaningful values. The average fcf levered cumulative growth (3y) of companies in the sector is -21.1% with a standard deviation of 196.8%.

Novartis AG's FCF Levered Cumulative Growth (3y) of 16.1% ranks in the 52.8% percentile for the sector. The following table provides additional summary stats:

FCF Levered Cumulative Growth (3y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,973
Included Constituents1,895
Min-1,245.1%
Max675.5%
Median6.9%
Mean-21.1%
Standard Deviation196.8%

You can find companies with similar fcf levered cumulative growth (3y) using this stock screener.

All rights reserved. Terms Of Use